SETD7 and cancer: Mutations that impair HIF‐1α methylation, such as serine 28 tyrosine (S28Y) and arginine 30 glutamine (R30Q) within the SET7/9 targeting consensus sites, have been identified in human cancers, suggesting the critical role of methylation in cancer biology.